ARCHIVES

Varmus Appoints Group On Intellectual Property

This article is from The Cancer Letter archive.

Vol. 24 No. 18 | May 8, 1998

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Clinton Declares Month of April Cancer Control Month

April 11, 1997

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

Scatter Radiation from Mammography Presents No Increased Cancer Risk

December 28, 2012

Bristol-Myers Nominations Open

August 10, 1979

$20 Million In Construction Funds Approved

April 2, 1976